Regenxbio (RGNX) Return on Sales (2016 - 2025)
Historic Return on Sales for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to 2.08%.
- Regenxbio's Return on Sales rose 3800.0% to 2.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.1%, marking a year-over-year increase of 17300.0%. This contributed to the annual value of 2.73% for FY2024, which is 1900.0% up from last year.
- Regenxbio's Return on Sales amounted to 2.08% in Q3 2025, which was up 3800.0% from 3.32% recorded in Q2 2025.
- Over the past 5 years, Regenxbio's Return on Sales peaked at 0.74% during Q4 2021, and registered a low of 4.06% during Q1 2024.
- Over the past 5 years, Regenxbio's median Return on Sales value was 2.46% (recorded in 2024), while the average stood at 2.39%.
- Its Return on Sales has fluctuated over the past 5 years, first tumbled by -26500bps in 2022, then soared by 41200bps in 2025.
- Quarter analysis of 5 years shows Regenxbio's Return on Sales stood at 0.74% in 2021, then tumbled by -359bps to 1.91% in 2022, then plummeted by -48bps to 2.84% in 2023, then rose by 15bps to 2.42% in 2024, then grew by 14bps to 2.08% in 2025.
- Its last three reported values are 2.08% in Q3 2025, 3.32% for Q2 2025, and 0.07% during Q1 2025.